About Trio Lifescience Private Limited
Data last updated:
Trio Lifescience Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 August 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24232GJ2007PTC051543. Its GSTIN is 24AADCT0969P1ZT (Gujarat).
The company has an authorised share capital of ₹11 Lakh and a paid-up capital of ₹11 Lakh. It is led by directors Amit Jayantkumar Vadhiya and Jayantkumar Nanjibhai Vadhiya.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot – 3008 Phase – IV GIDC Vatva, Ahmedabad, Gujarat, India – 382445.
As per the financials filed for FY 2024, the company reported a revenue of ₹8.48 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹12.43 Lakh (net margin 1.5%) and EBITDA of ₹73.8 Lakh (EBITDA margin 8.7%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 12% over five years.
The company has about 14 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Trio Lifescience. As per MCA filings, the company has open charges of ₹2 Cr on record. Court records list 3 cases involving the company, including 1 filed by the company and 2 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website triolifescience.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot – 3008 Phase – IV GIDC Vatva, Ahmedabad, Gujarat, India – 382445
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Trio Lifescience Private Limited
The main business activity of Trio Lifescience is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Trio Lifescience Private Limited FY 2025 filings available
Trio Lifescience Private Limited reported revenue of ₹8.48 Cr (up 11% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Trio Lifescience Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 11% growth in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Trio Lifescience Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹73.8 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹12.43 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Trio Lifescience Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Trio Lifescience are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Trio Lifescience Private Limited
Trio Lifescience Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Iqgen-X Pharma Private Limited | ₹8.51 Cr (FY 2023) | •••• | •••• | -14.0% | •••• | Navi Mumbai, Maharashtra, India |
| Srikara Healthcare Services Private Limited | ₹8.5 Cr (FY 2024) | •••• | •••• | 96.0% | •••• | Hyderabad, Telangana, India |
| Alliance Device Care Private Limited | ₹8.5 Cr (FY 2025) | •••• | •••• | 294.0% | •••• | Indore, Madhya Pradesh, India |
| Sudisa Industries Private Limited | ₹8.5 Cr (FY 2025) | •••• | •••• | 106.0% | •••• | Indore, Madhya Pradesh, India |
| Zenith Biosciences and Research Centre Private Limited | ₹8.49 Cr (FY 2025) | •••• | •••• | 82.0% | •••• | Patna, Bihar, India |
| Trio Lifescience Private Limited this company | ₹8.48 Cr (FY 2024) | •••• | •••• | 11.0% | •••• | Ahmedabad, Gujarat, India |
| Bhawani Acids & Alkalies Private Limited | ₹8.46 Cr (FY 2024) | •••• | •••• | 17.0% | •••• | Uttar Pradesh, India |
| S K Solvochem Private Limited | ₹8.45 Cr (FY 2025) | •••• | •••• | 221.0% | •••• | Chandigarh, India |
| Gentech Laboratories Private Limited | ₹8.43 Cr (FY 2024) | •••• | •••• | 39.0% | •••• | Mumbai, Maharashtra, India |
| Sr Pharmaceutical Industries Private Limited | ₹8.43 Cr (FY 2024) | •••• | •••• | 18.0% | •••• | New Delhi, Delhi, India |
| Galaxy Vitacare Private Limited | ₹8.4 Cr (FY 2025) | •••• | •••• | 3356.0% | •••• | Bhiwandi, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Trio Lifescience by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Trio Lifescience Private Limited
Trio Lifescience Private Limited is audited by MINESH MEHTA & CO for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MINESH MEHTA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Trio Lifescience Private Limited
Trio Lifescience has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Jayantkumar Vadhiya | Director | 20 Aug 2007 | 19 Years 1 Months | Current |
| Jayantkumar Nanjibhai Vadhiya | Director | 31 Mar 2015 | 11 Years 6 Months | Current |
Ownership and Shareholding of Trio Lifescience Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Trio Lifescience Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jun 2011 | Others | ₹1.5 Cr | Open |
| 25 Feb 2008 | The Ahmedabad Mercantile Co.Op.Bank Ltd. | ₹25 Lakh | Open |
| 22 Feb 2008 | The Ahmedabad Mercantile Co.Op.Bank Ltd. | ₹25 Lakh | Open |
Total charge records: 3 View all charges
Legal Cases of Trio Lifescience Private Limited
Trio Lifescience Private Limited has 3 court cases on record: 1 filed by Trio Lifescience, 2 filed against it. 1 case is pending and 2 are disposed. Status as checked between 02 Oct 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 2 | 1 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed by the company against an individual | Pending |
| District court, Wayanad, Kerala | Criminal complaint | Filed against the company by an individual | Disposed |
| District court, Wayanad, Kerala | Criminal complaint | Filed against the company by an individual | Disposed |
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Trio Lifescience Private Limited
Trio Lifescience operates one associated brand: Trio Lifescience. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of generic tablets, capsules, syrup, creams, and injectables | triolifescience.com |
Employees and EPFO Compliance at Trio Lifescience Private Limited
Trio Lifescience Private Limited has a workforce of 14 employees as of Apr 06, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Trio Lifescience Private Limited
Trio Lifescience Private Limited has 3 board changes on record since 2007: 2 appointments and 1 cessation. The latest: Amritlal Punjalal Parsania ceased to be Director on 31 Mar 2015.
Credit Ratings, Litigation & Regulatory Alerts for Trio Lifescience Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Trio Lifescience Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Trio Lifescience Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Trio Lifescience Private Limited
Trio Lifescience has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AADCT0969P1ZT | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Trio Lifescience Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Trio Lifescience Private Limited
Trio Lifescience is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 August 2007 (19+ years old) and is registered under CIN U24232GJ2007PTC051543.
Trio Lifescience reported revenue of ₹8.48 Cr for FY 2024 (up 11% YoY).
Trio Lifescience has 2 current directors:
- Amit Jayantkumar Vadhiya - Director
- Jayantkumar Nanjibhai Vadhiya - Director
Trio Lifescience reported a net profit of ₹12.43 Lakh (net margin 1.5%) and EBITDA of ₹73.8 Lakh (EBITDA margin 8.7%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Trio Lifescience is 19% over three years and 12% over five years. In the latest year (FY 2024) revenue rose 11%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Trio Lifescience is 24AADCT0969P1ZT, registered in Gujarat.
The CIN (Corporate Identification Number) of Trio Lifescience is U24232GJ2007PTC051543. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Trio Lifescience has 3 court cases on record: 1 filed by the company and 2 filed against it. 1 is pending.
Trio Lifescience was incorporated on 20 August 2007, making it 19+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Trio Lifescience by revenue are Iqgen-X Pharma Private Limited, Srikara Healthcare Services Private Limited, Alliance Device Care Private Limited, Sudisa Industries Private Limited, Zenith Biosciences and Research Centre Private Limited and 5 more, all in the Pharma industry (Formulations).
Amritlal Punjalal Parsania ceased to be Director on 31 Mar 2015. Jayantkumar Nanjibhai Vadhiya was appointed as Director on 31 Mar 2015. Amit Jayantkumar Vadhiya was appointed as Director on 20 Aug 2007.